Nolvadex: Instructions for use, contraindications, and composition

Nolvadex

Active substance: Tamoxifen. Nolvadex is able to cause ovulation in women; In men with oligospermia it increases concentration of hormones.

Pharmacological groups

Estrogens, progestins; antagonists, and their homologs

Antineoplastic hormonal and hormone antagonists

The nosological classification (ICD-10): C50 Malignant neoplasm of breast

Nolvadex: Product form - tablets of 10 mg, 60 or 250 pieces per pack. Nolvadex - a brand-name for the drug tamoxifen citrate (tamoxifen citrate), a non-steroidal substance that exhibits anti-estrogenic properties.

Nolvadex: Product form — tablets of 10 mg, 60 or 250 pieces per pack. Nolvadex — a brand-name for the drug tamoxifen citrate (tamoxifen citrate), a non-steroidal substance that exhibits anti-estrogenic properties.

Structure and Composition

1 coated tablet contains tamoxifen (citrate shaped) 10 or 20 mg; in blister 10 pcs., in a cardboard box of 3 blisters.

Pharmacologic effect:

Mode of action — anti-estrogen, anti-tumor.

Indications for use:

Mammary cancer.

Side effects

1 Hot flashes,

2 vaginal bleeding,

3 3endometrial hyperplasia,

4 vulvar itching,

5 diarrhea disorders,

6 dizziness,

7 water retention,

8 hypercalcemia,

9 anemia,

10 alopecia,

11 uterine fibroids,

12 leukopenia,

12 thromboembolism.

Dosing and Administration

Inside, in breast cancer — 20-40 mg / day (1 or 2 admission).

Contraindications

hypersensitivity;
pregnancy;
breastfeeding;
cataracts;
expressed thrombophlebitis;
leukopenia, thrombocytopenia.

Overdose

The drug causes increased side-effects. Symptomatic treatment. Antidote does not exist.